LyondellBasell Industries NV (LYB): Are Hedge Funds Right About This Stock?

Page 1 of 2

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile gigantic failures like hedge funds’ recent losses in Valeant. Let’s take a closer look at what the funds we track think about LyondellBasell Industries NV (NYSE:LYB) in this article.

LyondellBasell Industries NV (NYSE:LYB) has experienced an increase in hedge fund sentiment recently. LYB was in 51 hedge funds’ portfolios at the end of the third quarter of 2016. There were 43 hedge funds in our database with LYB holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Boston Scientific Corporation (NYSE:BSX), PG&E Corporation (NYSE:PCG), and Prudential Financial Inc (NYSE:PRU) to gather more data points.

Follow Lyondellbasell Industries N.v. (NYSE:LYB)

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

stem, molecular, test, dna, tube, background, chemistry, gene, helix, pharmaceutical, medical, formula, clone, biotech, atom, genetically, bio, render, biotechnology,


Now, we’re going to take a peek at the key action encompassing LyondellBasell Industries NV (NYSE:LYB).

What does the smart money think about LyondellBasell Industries NV (NYSE:LYB)?

At the end of the third quarter, a total of 51 of the hedge funds tracked by Insider Monkey were long this stock, a change of 19% from the previous quarter. With hedgies’ capital changing hands, there exists a select group of notable hedge fund managers who were increasing their stakes substantially (or already accumulated large positions).


Of the funds tracked by Insider Monkey, Soroban Capital Partners, managed by Eric W. Mandelblatt, holds the number one position in LyondellBasell Industries NV (NYSE:LYB). Soroban Capital Partners has a $445.2 million position in the stock, comprising 2.7% of its 13F portfolio. Coming in second is Viking Global, managed by Andreas Halvorsen, which holds a $319.4 million position; 1.4% of its 13F portfolio is allocated to the company. Some other professional money managers with similar optimism comprise Cliff Asness’ AQR Capital Management, and David Cohen and Harold Levy’s Iridian Asset Management.

Page 1 of 2